Identification of cardiometabolic risk among collegiate football players

Journal of Athletic Training

Volumn 45, Issue 1, 2010, Pages 67-74

  Wilkerson, Gary B ^a   Bullard, J Todd ^a   Bartal, David W ^a  

^a UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

Author keywords

Abdominal fat; Insulin resistance; Metabolic syndrome

Indexed keywords

ABDOMINAL FAT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FOOTBALL; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; UNIVERSITY;

ABDOMINAL FAT; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FOOTBALL; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; OBESITY; OVERWEIGHT; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; UNITED STATES; UNIVERSITIES; YOUNG ADULT;

EID: 75649142563     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: 10.4085/1062-6050-45.1.67     Document Type: Article

References (50)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA. 2002;288(21):2709-2716.
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24(4):683-689.
3. Buell JL, Calland D, Hanks F, et al. Presence of metabolic syndrome in football linemen. J Athl Train. 2008;43(6):608-616.
4. Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006;332(7546):878-882.
5. Li C, Ford ES. Definition of the metabolic syndrome: what's new and what predicts risk? Metab Syndr Relat Disord. 2006;4(4):237-251.
6. Park YW, Shankuan Z, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-436. (Pubitemid 36241019)
7. Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
8. Grundy SM. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol. 2005;25(11): 2243-2244.
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3): 356-359.
10. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005;28(4):878-881.
11. Huang TT, Shimel A, Lee RE, Delancy W, Strother ML. Metabolic risks among college students: prevalence and gender differences. Metab Syndr Relat Disord. 2007;5(4):365-372.
12. Huang TT, Kempf AM, Strother ML, et al. Overweight and components of the metabolic syndrome in college students. Diabetes Care. 2004;27(12):3000-3001.
13. Wang J, Thornton JC, Bari S, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003;77(2):379-384.
14. Ball SD, Altena TS. Comparison of the Bod Pod and dual energy xray absorptiometry in men. Physiol Meas. 2004;25(3):671-678.
15. Collins MA, Millard-Stafford ML, Sparling PB, et al. Evaluation of the BOD POD for assessing body fat in collegiate football players. Med Sci Sports Exerc. 1999;31(9):1350-1356.
16. McCrory MA, Gomez TD, Bernauer EM, Mole PA. Evaluation of a new air displacement plethysmograph for measuring human body composition. Med Sci Sports Exerc. 1995;27(12):1686-1691.
17. Carey M, Markham CM, Gaffney P, Boran C, Maher V. Validation of a point of care lipid analyzer using a hospital based reference laboratory. Ir J Med Sci. 2006;175(4):30-35.
18. Panz VR, Raal FJ, Paiker J, Immelman R, Miles H. Performance of the CardioCheck PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for measurement of lipids. Cardiovasc J S Afr. 2005, 16(2):112-117.
19. Shephard MD, Mazzachi BC, Shephard AK. Comparative performance of two point-of-care analysers for lipid testing. Clin Lab. 2007;53(9-12):561-566.
20. Pincivero DM, Lephart SM, Karunakara RA. Reliability and precision of isokinetic strength and muscular endurance for the quadriceps and hamstrings. Int J Sports Med. 1997;18(2):113-117.
21. Keskula DR, Dowling JS, Davis VL, Finley PW, Dell'Omo DL. Interrater reliability of isokinetic measures of knee flexion and extension. J Athl Train. 1995;30(2):167-170.
22. Feiring DC, Ellenbecker TS, Derscheid GL. Test-retest reliability of the Biodex isokinetic dynamometer. J Orthop Sports Phys Ther. 1990;11(7):298-300.
23. Kahn R. Metabolic syndrome: is it a syndrome? Does it matter? Circulation. 2007;115(113):1806-1810.
24. Liao Y, Kwon S, Shaughnessy S, Wallace P, et al. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004;27(4):978-983.
25. McLaughlin T, Abassi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med. 2003;139(10):802-809.
26. Cheal KL, Abassi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes. 2004;53(5):1195-1200.
27. Sierra-Johnson J, Johnson BD, Allison TG, Bailey KR, Schwartz GL, Turner ST. Correspondence between adult treatment panel III criteria for metabolic syndrome and insulin resistance. Diabetes Care. 2006;29(3):668-672.
28. Rutter MK, Meigs JB, Wilson PW. Cardiovascular risk and the metabolic syndrome. Metab Syndr Relat Disord. 2006;4(4):252-260.
29. Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10): 812-819.
30. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245-1250.
31. Kahn R, Buse J, Ferrannini E, Stern M, the America Diabetes Association, the European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9): 2289-2304. (Pubitemid 41242486)
32. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769-1778.
33. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113(25):2943-2946. (Pubitemid 44297236)
34. Wong ND. The metabolic syndrome and preventive cardiology: working together to reduce cardiometabolic risks. Metab Syndr Relat Disord. 2006;4(4):233-236.
35. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45(6):742-748.
36. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol. 2007;49(8):891-898.
37. Franklin SS. Hypertension in the metabolic syndrome. Metab Syndr Relat Disord. 2006;4(4):287-298.
38. Bosy-Westphal A, Geisler C, Onur S, et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes Lond. 2006;30(3):475-483.
39. Gerich JE. Glycemic control in the metabolic syndrome and implications in preventing cardiovascular disease. Metab Syndr Relat Disord. 2006;4(4):315-327.
40. Jurca R, LaMonte MJ, Barlow CE, Kampert JB, Church TS, Blair SN. Association of muscular strength with incidence of metabolic syndrome in men. Med Sci Sports Exerc. 2005;37(11):1849-1855.
41. Honkola A, Forsen T, Eriksson J. Resistance training improves the metabolic profile in individuals with type 2 diabetes. Acta Diabetol. 1997;34(4):245-248.
42. Steele RM, Brage S, Corder K, Wareham NJ, Ekelund U. Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth. J Appl Physiol. 2008;105(1):342-351.
43. Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med. 2004;164(10):1092-1097.
44. Churilla JF, Zoeller RF Jr. Physical activity and the metabolic syndrome: a review of the evidence. Am J Lifestyle Med. 2008;2(2):118-125.
45. Jurca R, LaMonte MJ, Church TS, et al. Associations of muscle strength and aerobic fitness with metabolic syndrome in men. Med Sci Sports Exerc. 2004;36(8):1301-1307.
46. Horowitz JF. Exercise-induced alterations in muscle lipid metabolism improve insulin sensitivity. Exerc Sport Sci Rev. 2007;35(4):192-196.
47. Pereira LO, Lancha AH Jr. Effect of insulin and contraction upon glucose transport in skeletal muscle. Prog Biophys Mol Biol. 2004;84(1):1-27.
48. Richter EA, Derave W, Wojtaszewski JF. Glucose, exercise, and insulin: emerging concepts. J Physiol. 2001;535(2):313-322.
49. Esposito K, Ceriello A, Giugliano D. Diet and the metabolic syndrome. Metab Syndr Relat Disord. 2007;5(4):291-296.
50. Mitrou PN, Kipnis V, Thiebaut AC, et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the JIH-AARP Diet and Health Study. Arch Intern Med. 2007;167(22):2461-2468.